Global Cryopreservation for In-Vitro Fertilization (IVF) Market Report and Forecast 2024-2032

Global Cryopreservation for In-Vitro Fertilization (IVF) Market Outlook

The global cryopreservation for in-vitro fertilization (IVF) market size was valued at USD 456.23 million in 2023 with the rising incidence of infertility and increased understanding on egg freezing. The market is expected to grow at a CAGR of 10.6% during the forecast period of 2024-2032, with the values likely to rise from USD 504.58 million in 2024 to USD 1129.73 million by 2032.

Cryopreservation for In-Vitro Fertilization (IVF): Introduction

Cryopreservation is the process of freezing and storing eggs (oocytes), sperms, or embryos for future use. It can help people preserve their future fertility. Cryopreservation is generally advised to people undergoing chemotherapy and radiations as these treatments can damage a person’s fertility. People engrossed in career also consider cryopreservation as it offers an opportunity to them to have a child later. The rising prevalence of fertility issues and the consequent rise in the demand for IVF is anticipated to provide significant impetus to the cryopreservation for in-vitro fertilization (IVF) market growth in the coming years.

Cryopreservation is done with the help of liquid nitrogen, freezing the cells to -320 degrees Fahrenheit. The cells are then stored in a lab or commercial reproductive medicine centres safely and can be preserved up to ten years or longer. Labs mostly use cryoprotective agents like glycols to prevent the cells from damage.

Global Cryopreservation for In-Vitro Fertilization (IVF) Market Analysis

Nowadays, majority of women are facing infertility problems due to a variety of factors like hectic lifestyles, food habits, and lack of exercise. The prevalence of these issues can also be attributed to invasive cancer treatments, declining oocyte quality with age, polycystic ovary syndrome (PCOS), or premature ovarian failure (POF). As per recent trends, most women prefer delaying childbearing until 35 years or later. Hence, cryopreservation for in-vitro fertilization (IVF) market demand has increased over the years.

Breast cancer is the common type of cancer affecting most women in their reproductive age. Talking about the United States alone, 15%  of the women affected with breast cancer are under 45 years of age. As they undergo chemotherapy regimens, cyclophosphamide, which is the common alkylating agent in chemotherapy, deteriorates the ovarian follicle reserve. Breast cancer is the most common type of cancer in women, accounting for 12.5%  of the total new cancer cases annually. With the rising incidence rate of breast cancer, the cryopreservation for in-vitro fertilization (IVF) market value is also expected to increase during the forecast period.

Cryopreservation is done via two processes, namely slow freezing, and vitrification. Despite successful cryopreservation outcomes, there are still high chances of DNA deformation, chromosomal abnormalities, and spindle deformation. There has been critical research around the decreasing the anomaly rates. Currently, ovarian tissue cryopreservation is under investigation. It allows the benefits of preserving thousands of primordial follicles at a time. This technique emerges to serve women with hormone-sensitive cancers as well.

Global Cryopreservation for In-Vitro Fertilization (IVF) Market Segmentation

Market Breakup by Type

• Cryopreservation Media

• Cryopreservation Storage Devices

• Consumables

• Accessories

• Cryo-shipping

• Others

Market Breakup by Applications

• Oocyte Cryopreservation

• Sperm Cryopreservation

• Embryo Cryopreservation

• Others

Market Breakup by End User

• Biobanks

• IVF Centres

• Fertility Clinics

• Research and Academic Institutes

• Cryo-shipping/ Couriers

Market Breakup by Region

• North America

• Europe

• Asia Pacific

• Latin America

• Middle East and Africa

Global Cryopreservation for In-Vitro Fertilization (IVF) Market Overview

The cause of in-vitro fertilization has been redefined with the passage of time. Initially, it was used to treat infertile couples, but now the utility has expanded to fertility preservation. The overall access and utilization of IVF varies across the globe, but around 5% of the newborns in the European region are an outcome of an in-vitro fertilisation procedure.

With evolving socio-cultural demographics, there is a rising trend of fertility preservation, especially with women getting educated and excelling in their careers. In metropolitan areas, the average age of a woman bearing the first child has exceeded to 30s, which earlier used to be around 20s. The trend seems to continue in the coming years with the population being more aware about the expenses of raising a child and the need for planning and preparation.

The constant debate around cryopreservation legalisation in the countries has been an obstacle in the cryopreservation for in-vitro fertilization (IVF) market growth but it is gradually becoming a norm, especially in the metropolitan cities. Recently, cryopreservation has been legalised in countries like Taiwan, Japan, Singapore, and South Korea. This indicates that the Asian territory is likely to hold a massive portion of the global cryopreservation for in-vitro fertilization (IVF) market share in the coming years.

Global Cryopreservation for In-Vitro Fertilization (IVF) Market: Competitor Landscape

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:

• Cryotech

• Cook Medical LLC

• Fujifilm Irvine Scientific

• Thermo Fisher Scientific Inc

• Coldstash Inc.

• Vitromed GmbH

• Corning Incorporated

• Cryogatt Systems Ltd

• Brook Life Sciences

• Cryo Solutions B.V

Key Highlights of the Report